Tevogen Bio Holdings's market cap is currently $127.62M. The company's EPS TTM is $-0.031; its P/E ratio is ―; Tevogen Bio Holdings is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
